Cardiac arrest & resuscitation

Temporal trends in organ donation among cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation

ResuscitationPublished Retrospective cohort study

Authors' conclusion

The public health benefits of an established ECPR program extend beyond individual ECPR patient survival, forming a new, previously under-recognized source of transplant donors.

Study context

Population
Patients with refractory out-of-hospital-cardiac-arrest (OHCA), mostly initial shockable rhythms, treated with extracorporeal-cardiopulmonary-resuscitation (ECPR), 2016–2023
Participants
419 patients
Outcome
Organ donation rate among non-survivors; public health benefit of ECPR (survivors with CPC 1-2 plus non-survivors donating ≥1 solid organ, over total ECPR patients)
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Survived neurologically intact
116 (27.7%)
Non-survivors whose families consented to organ donation
41 (13.5%) of 303
Donors with organs harvested
38
Organ transplants
74 to 73 recipients
Accepted organs/donor
2.4 ± 0.9
Organ donors correlated with years since ECPR program initiation
ptrend = 0.009
Successful transplants correlated with years since ECPR program initiation
ptrend = 0.01
Cumulative public health benefit of ECPR (116 survivors and 38 donors)
36.8%

Observational data: associations, not effects.

Further findings

Transplanted organs

Kidneys
43 (58.1%)
Livers
27 (36.5%)
Lungs
3 (4%)
Heart
1 (1.4%)

Patients benefiting from ECPR (organ-failure-free survival)

Total benefited (116 survivors, 73 organ recipients)
189

Consenting donors' characteristics

Median age
51 years
Male
75.6%

Original publication

Temporal trends in organ donation among cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation. Resuscitation. Published 5 September 2024. doi:10.1016/j.resuscitation.2024.110391

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.